secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2023-01-10T23:59:59+00:00
Accession:  0001438133-23-000005
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes announces preliminary FY2022 results and FY2023 guidance; no specific figures disclosed in filing text
--------------------------------------------------------------------------------

- Press release contains unaudited preliminary Q4 and full-year 2022 results.
- Results are preliminary and subject to adjustment; final audited results will be in the 10-K.
- Company also provided preliminary financial guidance for the full year ending December 31, 2023.
- Exhibit 99.1 text was not included in the provided filing, so specific numbers are unavailable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000005/0001438133-23-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000005/tndm-20230110.htm
  HTML page:      https://secwatch.observer/filing/0001438133-23-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer